| NCT ID | NCT03005002 |
| Title | Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | yes |
| Sponsors | City of Hope Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |